Agrani Dixit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Agrani Dixit has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alexis Erasta Carey
Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 1
12 shared publications - Andrew V. Kossenkov
The Wistar Institute, Philadelphia, Pennsylvania
12 shared publications - Ashani T. Weeraratna
Johns Hopkins University
12 shared publications - David W. Speicher
The Wistar Institute, Philadelphia, Pennsylvania, USA
12 shared publications - Denis Wirtz
Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA
12 shared publications - Gretchen M. Alicea
Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 1
12 shared publications
Latest Publications
- Open Access
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
- Open Access
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.
- Open Access
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
- Open Access
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Data from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment.Significance:The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.
- 1 April 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment.Significance:The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.
- Open Access
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Data from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment.Significance:The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients (5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment.Significance:The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.
- Open Access
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
- Open Access
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
- Open Access
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supplemental Figure 2 shows melanoma cells treated with Albumax, as well as an additional cell line showing the contribution of IGFBP2 to invasion
- Open Access
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Supp Fig 3 shows the zoom -out of Figure 4, to show a larger field of view for staining of mCherry cells
- Open Access
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.
- 6 August 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Age-Related Increases in IGFBP2 Increase Melanoma Cell Invasion and Lipid Synthesis
Overview of IGFBP2 expression in patient data bases, additional pAKT staining, and oil red O zoom out.